SurModics (SRDX) Tops Q4 EPS by 4c
Tweet
Share
E-mailGet Alerts SRDX Hot Sheet
Price: $42.98 --0%
Financial Fact:
Net income (loss): 2.64M
Today's EPS Names:
CRMT, FOMI, FLES, More
Financial Fact:
Net income (loss): 2.64M
Today's EPS Names:
CRMT, FOMI, FLES, More
Join SI Premium – FREE
SurModics (NASDAQ: SRDX) reported Q4 EPS of $0.25, $0.04 better than the analyst estimate of $0.21. Revenue for the quarter came in at $14.2 million versus the consensus estimate of $14.3 million.
For earnings history and earnings-related data on SurModics (SRDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump discloses over $1.4 billion in crypto income in 2025 filing
- William Blair on TransMedics Group (TMDX): 'We believe TransMedics’ second-quarter sales will exceed consensus estimates'
- Columbus McKinnon names John Linker as CFO, reaffirms FY2027 guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
